CEFTRIAXONE

CEFTRIAXONE was reported 38983 times

CEFTRIAXONE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PSEUDOCHOLELITHIASIS 78 0.7290
1 APPENDICOLITH 186 0.4806
2 SLEEP DISORDER THERAPY 75 0.3788
3 ANTACID THERAPY 42 0.3231
4 FACTOR V INHIBITION 61 0.3144
5 ANALGESIC THERAPY 81 0.2523
6 POSTRENAL FAILURE 104 0.2364
7 DRUG THERAPY 78 0.2301
8 PENILE ABSCESS 20 0.2151
9 JARISCH-HERXHEIMER REACTION 140 0.1966
10 ACQUIRED FACTOR V DEFICIENCY 20 0.1818
11 ANTICOAGULANT THERAPY 42 0.1479
12 CONGENITAL HIATUS HERNIA 32 0.1404
13 MALIGNANT MELANOMA STAGE 0 29 0.1388
14 BACTEROIDES INFECTION 33 0.1264
15 RENAL PAPILLARY NECROSIS 22 0.1023
16 DISSEMINATED STRONGYLOIDIASIS 22 0.1005
17 PORTAL FIBROSIS 21 0.0981
18 CLOSTRIDIUM TEST POSITIVE 210 0.0952
19 PLEOCYTOSIS 49 0.0842
20 TRICHOSPORON INFECTION 32 0.0790
21 VITAMIN K DEFICIENCY 31 0.0771
22 DISSEMINATED ASPERGILLOSIS 34 0.0720
23 MORGANELLA INFECTION 21 0.0717
24 VANCOMYCIN INFUSION REACTION 26 0.0690
25 CALCULUS URETERIC 49 0.0677
26 PNEUMOCOCCAL INFECTION 40 0.0676
27 DISSEMINATED MUCORMYCOSIS 26 0.0660
28 INTENSIVE CARE UNIT ACQUIRED WEAKNESS 24 0.0632
29 GENERALISED BULLOUS FIXED DRUG ERUPTION 21 0.0565
30 CORYNEBACTERIUM INFECTION 30 0.0561
31 BRONCHOPLEURAL FISTULA 21 0.0559
32 BLOOD PHOSPHORUS INCREASED 139 0.0509
33 HYPERPHOSPHATAEMIA 108 0.0502
34 BLOOD GASES ABNORMAL 27 0.0501
35 ABDOMINAL COMPARTMENT SYNDROME 31 0.0487
36 PROPOFOL INFUSION SYNDROME 34 0.0482
37 INFECTIVE ANEURYSM 23 0.0465
38 KOUNIS SYNDROME 104 0.0458
39 CHOREOATHETOSIS 30 0.0442
40 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 335 0.0431
41 NOCARDIOSIS 110 0.0430
42 ACINETOBACTER INFECTION 47 0.0429
43 BRAIN ABSCESS 107 0.0422
44 CRYSTALLURIA 22 0.0404
45 PNEUMONIA NECROTISING 26 0.0402
46 SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA 32 0.0389
47 PULMONARY NOCARDIOSIS 32 0.0388
48 STENOTROPHOMONAS INFECTION 52 0.0383
49 DISSEMINATED CRYPTOCOCCOSIS 29 0.0383
50 EOSINOPHILIC PNEUMONIA ACUTE 33 0.0381
51 LINEAR IGA DISEASE 62 0.0372
52 ENDOCARDITIS BACTERIAL 29 0.0368
53 FUNGAEMIA 58 0.0368
54 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 940 0.0365
55 SPUTUM PURULENT 23 0.0350
56 ACQUIRED HAEMOPHILIA 35 0.0349
57 DYSMETRIA 21 0.0348
58 CEREBRAL ASPERGILLOSIS 21 0.0341
59 PSEUDOMEMBRANOUS COLITIS 76 0.0340
60 MUCORMYCOSIS 88 0.0338
61 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 31 0.0334
62 STRONGYLOIDIASIS 54 0.0334
63 ENTEROBACTER INFECTION 56 0.0333
64 VANISHING BILE DUCT SYNDROME 37 0.0332
65 TOXIC ENCEPHALOPATHY 163 0.0321
66 THERAPEUTIC PRODUCT CROSS-REACTIVITY 28 0.0314
67 RED MAN SYNDROME 27 0.0307
68 CYTOKINE STORM 21 0.0307
69 MENINGITIS BACTERIAL 42 0.0293
70 PNEUMONIA MYCOPLASMAL 23 0.0289
71 TOXIC EPIDERMAL NECROLYSIS 428 0.0282
72 CSF PROTEIN INCREASED 23 0.0277
73 KLEBSIELLA INFECTION 139 0.0275
74 TRACHEOBRONCHITIS 21 0.0273
75 LISTERIOSIS 30 0.0271
76 MYASTHENIA GRAVIS CRISIS 39 0.0263
77 BRONCHOPULMONARY ASPERGILLOSIS 204 0.0263
78 HAEMOPERITONEUM 21 0.0262
79 DYSBIOSIS 21 0.0256
80 PULMONARY CAVITATION 22 0.0253
81 SEPTIC EMBOLUS 21 0.0252
82 TOTAL LUNG CAPACITY DECREASED 40 0.0250
83 ENTEROCOCCAL INFECTION 121 0.0250
84 FIXED ERUPTION 43 0.0250
85 INTERVERTEBRAL DISCITIS 47 0.0249
86 PROCALCITONIN INCREASED 29 0.0247
87 SEPSIS NEONATAL 20 0.0246
88 MULTIPLE ORGAN DYSFUNCTION SYNDROME 691 0.0244
89 LONG QT SYNDROME 58 0.0242
90 EOSINOPHILIA 417 0.0238
91 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 118 0.0237
92 CLOSTRIDIUM DIFFICILE COLITIS 248 0.0234
93 LUNG OPACITY 61 0.0231
94 APPENDICITIS 213 0.0228
95 MULTIPLE-DRUG RESISTANCE 69 0.0222
96 CEREBRAL PALSY 21 0.0221
97 VENTRICULAR FIBRILLATION 244 0.0219
98 PNEUMOCYSTIS JIROVECII INFECTION 26 0.0218
99 APGAR SCORE LOW 28 0.0217
100 RASH MORBILLIFORM 59 0.0213
101 PYURIA 21 0.0212
102 HYPOFIBRINOGENAEMIA 21 0.0212
103 SYSTEMIC CANDIDA 53 0.0211
104 HAEMOLYTIC ANAEMIA 189 0.0211
105 AUTOIMMUNE HAEMOLYTIC ANAEMIA 72 0.0210
106 IRON DEFICIENCY 94 0.0209
107 CRYPTOCOCCOSIS 34 0.0208
108 BLOOD URIC ACID INCREASED 120 0.0208
109 SECONDARY IMMUNODEFICIENCY 25 0.0206
110 CARDIOGENIC SHOCK 292 0.0203
111 PATHOGEN RESISTANCE 184 0.0202
112 HYDRONEPHROSIS 150 0.0200
113 URETERIC OBSTRUCTION 27 0.0198
114 ENCEPHALITIS AUTOIMMUNE 26 0.0198
115 LOW BIRTH WEIGHT BABY 156 0.0196
116 EMPYEMA 39 0.0196
117 MIXED LIVER INJURY 59 0.0196
118 CALCULUS URINARY 30 0.0195
119 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 98 0.0193
120 PNEUMONIA STREPTOCOCCAL 21 0.0192
121 RASH MACULO-PAPULAR 424 0.0190
122 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 61 0.0188
123 PULMONARY FUNCTION TEST ABNORMAL 29 0.0186
124 TYPE IV HYPERSENSITIVITY REACTION 51 0.0186
125 HYPERTRANSAMINASAEMIA 129 0.0185
126 DEVICE RELATED SEPSIS 37 0.0184
127 HYPERLACTACIDAEMIA 49 0.0183
128 ISCHAEMIC HEPATITIS 25 0.0182
129 NEPHRITIS INTERSTITIAL 23 0.0182
130 LUNG ABSCESS 38 0.0181
131 HAEMODYNAMIC INSTABILITY 138 0.0181
132 LUNG CONSOLIDATION 50 0.0179
133 ACUTE RESPIRATORY DISTRESS SYNDROME 312 0.0176
134 ENDOCARDITIS 90 0.0175
135 HEPATITIS CHOLESTATIC 105 0.0174
136 CEREBELLAR SYNDROME 38 0.0173
137 TORSADE DE POINTES 136 0.0173
138 HYPOPHOSPHATAEMIA 128 0.0173
139 AGRANULOCYTOSIS 321 0.0173
140 MYASTHENIA GRAVIS 138 0.0171
141 BRAIN HERNIATION 51 0.0171
142 ASPERGILLUS INFECTION 112 0.0170
143 HEPATITIS TOXIC 44 0.0169
144 QUADRIPARESIS 28 0.0169
145 RESPIRATORY ALKALOSIS 27 0.0166
146 PNEUMOMEDIASTINUM 30 0.0166
147 HISTIOCYTOSIS HAEMATOPHAGIC 49 0.0165
148 HEPATOSPLENOMEGALY 42 0.0163
149 NOSOCOMIAL INFECTION 36 0.0163
150 CARDIAC VENTRICULAR THROMBOSIS 21 0.0163
151 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 62 0.0162
152 STATUS EPILEPTICUS 183 0.0162
153 ENCEPHALITIS 112 0.0162
154 CHOLESTATIC LIVER INJURY 36 0.0162
155 PNEUMONIA STAPHYLOCOCCAL 31 0.0157
156 TUBULOINTERSTITIAL NEPHRITIS 294 0.0157
157 PULSELESS ELECTRICAL ACTIVITY 65 0.0155
158 PNEUMONIA PNEUMOCOCCAL 23 0.0155
159 DERMATITIS EXFOLIATIVE GENERALISED 54 0.0155
160 LEUKOCYTOSIS 280 0.0155
161 CHOLESTASIS 297 0.0155
162 RENAL TUBULAR NECROSIS 151 0.0154
163 SEPTIC SHOCK 659 0.0151
164 OTOTOXICITY 28 0.0151
165 INFLAMMATORY MARKER INCREASED 75 0.0151
166 HISTOPLASMOSIS DISSEMINATED 24 0.0151
167 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 35 0.0150
168 BRONCHIAL OBSTRUCTION 21 0.0149
169 MENINGITIS CRYPTOCOCCAL 26 0.0149
170 PNEUMONIA KLEBSIELLA 27 0.0147
171 MEGACOLON 23 0.0146
172 AORTIC STENOSIS 51 0.0146
173 NORMOCYTIC ANAEMIA 21 0.0143
174 ACUTE RESPIRATORY FAILURE 274 0.0142
175 TACHYPNOEA 193 0.0142
176 TROPONIN INCREASED 108 0.0142
177 OLIGURIA 88 0.0142
178 ALVEOLITIS 20 0.0142
179 ANURIA 119 0.0138
180 INFECTIOUS PLEURAL EFFUSION 21 0.0138
181 PREMATURE DELIVERY 219 0.0137
182 BACTERAEMIA 163 0.0137
183 FOETAL DISTRESS SYNDROME 29 0.0137
184 VASCULAR DEVICE INFECTION 62 0.0137
185 RETROPERITONEAL HAEMATOMA 30 0.0136
186 ESCHERICHIA INFECTION 111 0.0135
187 CLOSTRIDIUM DIFFICILE INFECTION 294 0.0135
188 BREATH SOUNDS ABNORMAL 66 0.0134
189 COVID-19 PNEUMONIA 158 0.0134
190 EOSINOPHILIC PNEUMONIA 42 0.0133
191 DRUG-INDUCED LIVER INJURY 417 0.0133
192 BRAIN DEATH 41 0.0133
193 BICYTOPENIA 26 0.0133
194 PYELONEPHRITIS ACUTE 26 0.0132
195 HAEMOLYSIS 102 0.0132
196 HYPOVOLAEMIC SHOCK 63 0.0131
197 STEVENS-JOHNSON SYNDROME 291 0.0131
198 CHEST X-RAY ABNORMAL 40 0.0130
199 ENCEPHALOPATHY 319 0.0130
200 BLOOD LACTIC ACID INCREASED 68 0.0129
201 DIABETES INSIPIDUS 31 0.0129
202 ELECTROCARDIOGRAM QT PROLONGED 463 0.0129
203 DISSEMINATED INTRAVASCULAR COAGULATION 180 0.0128
204 HEPATOCELLULAR INJURY 181 0.0128
205 CLOSTRIDIAL INFECTION 42 0.0124
206 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 33 0.0124
207 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 93 0.0124
208 BACTERIAL INFECTION 230 0.0123
209 PLEURITIC PAIN 34 0.0123
210 FOETAL GROWTH RESTRICTION 74 0.0122
211 HEPATITIS FULMINANT 36 0.0121
212 PARTIAL SEIZURES 63 0.0120
213 IMMUNE THROMBOCYTOPENIA 55 0.0120
214 HEPATIC CYTOLYSIS 153 0.0120
215 RESPIRATORY ACIDOSIS 47 0.0119
216 HYPERCAPNIA 36 0.0119
217 ARTHRITIS BACTERIAL 49 0.0119
218 MENINGITIS ASEPTIC 53 0.0118
219 OTITIS MEDIA 39 0.0118
220 STAPHYLOCOCCAL BACTERAEMIA 51 0.0117
221 PNEUMONIA BACTERIAL 106 0.0115
222 TRANSAMINASES INCREASED 254 0.0114
223 ACUTE PULMONARY OEDEMA 64 0.0114
224 ESCHERICHIA SEPSIS 33 0.0114
225 NEPHROPATHY TOXIC 126 0.0112
226 CHOLANGITIS SCLEROSING 23 0.0112
227 PULSE ABSENT 53 0.0111
228 GENE MUTATION 22 0.0111
229 LIVER ABSCESS 36 0.0111
230 HYPOXIA 389 0.0110
231 DRUG RESISTANCE 282 0.0110
232 HEPATITIS 280 0.0109
233 CANDIDA INFECTION 184 0.0109
234 ORAL PRURITUS 25 0.0109
235 ACUTE KIDNEY INJURY 1662 0.0108
236 PURPURA 96 0.0108
237 NEUROTOXICITY 190 0.0108
238 HYPERNATRAEMIA 54 0.0108
239 ASCITES 318 0.0108
240 NEPHRITIS 36 0.0108
241 COMA SCALE ABNORMAL 31 0.0107
242 HYPERTENSIVE HEART DISEASE 20 0.0107
243 BLOOD CULTURE POSITIVE 32 0.0107
244 CHOLANGITIS 66 0.0106
245 VARICELLA ZOSTER VIRUS INFECTION 22 0.0106
246 DIPLEGIA 21 0.0106
247 PREMATURE BABY 318 0.0106
248 RESPIRATORY FAILURE 760 0.0104
249 FIBRIN D DIMER INCREASED 37 0.0104
250 PYELONEPHRITIS 90 0.0104
251 NEUROLOGICAL DECOMPENSATION 24 0.0104
252 HEPATIC NECROSIS 39 0.0103
253 ANAPHYLACTIC SHOCK 266 0.0103
254 HEPATITIS ACUTE 67 0.0103
255 HYPERSENSITIVITY VASCULITIS 27 0.0103
256 NEONATAL RESPIRATORY DISTRESS SYNDROME 36 0.0102
257 HEPARIN-INDUCED THROMBOCYTOPENIA 50 0.0101
258 RETROPERITONEAL HAEMORRHAGE 25 0.0101
259 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 25 0.0101
260 HEPATOMEGALY 99 0.0101
261 TOXIC SKIN ERUPTION 101 0.0100
262 FOETAL DEATH 52 0.0100
263 STAPHYLOCOCCUS TEST POSITIVE 21 0.0100
264 SHOCK HAEMORRHAGIC 81 0.0099
265 ABDOMINAL WALL HAEMATOMA 19 0.0097
266 TYPE I HYPERSENSITIVITY 34 0.0097
267 SHOCK 221 0.0096
268 HENOCH-SCHONLEIN PURPURA 21 0.0096
269 RESPIRATORY DISTRESS 265 0.0096
270 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 25 0.0095
271 INTRACRANIAL PRESSURE INCREASED 53 0.0095
272 NEUTROPHILIA 54 0.0095
273 FEBRILE BONE MARROW APLASIA 40 0.0094
274 METABOLIC ENCEPHALOPATHY 28 0.0093
275 PANCREATITIS NECROTISING 21 0.0091
276 LYMPHADENITIS 22 0.0091
277 FLANK PAIN 85 0.0091
278 PRIAPISM 31 0.0090
279 MENINGITIS 60 0.0090
280 PNEUMOCYSTIS JIROVECII PNEUMONIA 90 0.0090
281 BENIGN PROSTATIC HYPERPLASIA 46 0.0089
282 NEPHROGENIC ANAEMIA 41 0.0088
283 DERMATITIS BULLOUS 64 0.0088
284 STRIDOR 26 0.0088
285 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 482 0.0088
286 RALES 51 0.0088
287 CHOLELITHIASIS 285 0.0087
288 SKIN NECROSIS 45 0.0087
289 CHOLECYSTITIS ACUTE 49 0.0086
290 ACIDOSIS 66 0.0086
291 EAR PRURITUS 30 0.0085
292 COAGULOPATHY 142 0.0085
293 METABOLIC ACIDOSIS 272 0.0085
294 HYPONATRAEMIA 478 0.0085
295 RENAL FAILURE ACUTE 358 0.0084
296 CREPITATIONS 25 0.0084
297 LUNG INFILTRATION 74 0.0084
298 PSEUDOMONAS INFECTION 71 0.0083
299 END STAGE RENAL DISEASE 151 0.0083
300 STREPTOCOCCAL INFECTION 46 0.0083
301 UROSEPSIS 76 0.0082
302 ENDOTRACHEAL INTUBATION 23 0.0082
303 ACUTE HEPATIC FAILURE 112 0.0082
304 HYPOALBUMINAEMIA 63 0.0081
305 RESPIRATORY SYMPTOM 23 0.0081
306 STRESS CARDIOMYOPATHY 47 0.0081
307 ATELECTASIS 78 0.0081
308 OSTEOMYELITIS 146 0.0081
309 GUILLAIN-BARRE SYNDROME 39 0.0081
310 SPLENOMEGALY 94 0.0080
311 NORMOCHROMIC NORMOCYTIC ANAEMIA 24 0.0080
312 MULTI-ORGAN FAILURE 138 0.0080
313 ERYTHEMA NODOSUM 28 0.0080
314 SINUS BRADYCARDIA 77 0.0080
315 ANAPHYLACTIC REACTION 439 0.0079
316 MACULE 22 0.0079
317 NORMAL NEWBORN 43 0.0079
318 URINE OUTPUT DECREASED 69 0.0079
319 SEPSIS 879 0.0079
320 BILE DUCT STONE 25 0.0079
321 HYPERTHERMIA 60 0.0079
322 OESOPHAGEAL CANDIDIASIS 31 0.0078
323 AZOTAEMIA 31 0.0078
324 EUGLYCAEMIC DIABETIC KETOACIDOSIS 32 0.0077
325 ARTERIOSPASM CORONARY 31 0.0077
326 HYPERBILIRUBINAEMIA 80 0.0077
327 LIVER FUNCTION TEST INCREASED 162 0.0075
328 UNRESPONSIVE TO STIMULI 194 0.0075
329 DUODENITIS 23 0.0075
330 PULMONARY ALVEOLAR HAEMORRHAGE 42 0.0075
331 CYTOMEGALOVIRUS INFECTION REACTIVATION 33 0.0075
332 CARDIOPULMONARY FAILURE 29 0.0074
333 RHINITIS ALLERGIC 33 0.0074
334 DERMATITIS EXFOLIATIVE 37 0.0074
335 ANTINUCLEAR ANTIBODY POSITIVE 24 0.0074
336 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 126 0.0073
337 NYSTAGMUS 39 0.0073
338 LARGE INTESTINE PERFORATION 51 0.0073
339 HYPERPYREXIA 31 0.0073
340 PULMONARY TUBERCULOSIS 31 0.0072
341 PNEUMONIA VIRAL 23 0.0072
342 CYTOMEGALOVIRUS VIRAEMIA 32 0.0072
343 CARDIAC ARREST 589 0.0071
344 THROMBOPHLEBITIS 25 0.0071
345 CUTANEOUS VASCULITIS 26 0.0071
346 CYANOSIS 112 0.0071
347 PNEUMOTHORAX 112 0.0071
348 CATATONIA 37 0.0070
349 MYOCLONUS 84 0.0070
350 LIVER INJURY 172 0.0070
351 FULL BLOOD COUNT ABNORMAL 74 0.0070
352 THYROIDITIS 21 0.0070
353 DUODENAL ULCER 49 0.0069
354 OCULAR ICTERUS 30 0.0069
355 PETECHIAE 72 0.0069
356 ADENOVIRUS INFECTION 20 0.0069
357 STAPHYLOCOCCAL SEPSIS 34 0.0069
358 VASCULITIS 80 0.0069
359 ASPARTATE AMINOTRANSFERASE INCREASED 363 0.0068
360 NECROSIS 38 0.0068
361 SERUM FERRITIN INCREASED 36 0.0068
362 HYPOKALAEMIA 315 0.0068
363 DRUG ERUPTION 120 0.0068
364 TALIPES 21 0.0068
365 ALANINE AMINOTRANSFERASE INCREASED 414 0.0067
366 BRAIN OEDEMA 85 0.0067
367 RASH PUSTULAR 49 0.0067
368 LEUKOENCEPHALOPATHY 25 0.0067
369 PANCYTOPENIA 375 0.0067
370 STAPHYLOCOCCAL INFECTION 221 0.0067
371 PROTHROMBIN TIME PROLONGED 40 0.0067
372 THROMBOCYTOPENIA 747 0.0067
373 THROMBOTIC MICROANGIOPATHY 65 0.0067
374 HAEMODIALYSIS 56 0.0067
375 DRUG INTERACTION 1057 0.0067
376 GENERALISED TONIC-CLONIC SEIZURE 110 0.0066
377 RASH VESICULAR 32 0.0066
378 LIP OEDEMA 28 0.0066
379 ORAL CANDIDIASIS 87 0.0066
380 FOOD INTOLERANCE 24 0.0065
381 PLEURAL EFFUSION 397 0.0065
382 ERYTHEMA MULTIFORME 60 0.0064
383 INTERNATIONAL NORMALISED RATIO INCREASED 183 0.0064
384 BLOOD UREA INCREASED 107 0.0064
385 DRUG LEVEL BELOW THERAPEUTIC 35 0.0063
386 MENTAL STATUS CHANGES 176 0.0063
387 HYPERREFLEXIA 22 0.0063
388 RESPIRATORY RATE INCREASED 56 0.0063
389 SINUS TACHYCARDIA 89 0.0063
390 NECROTISING FASCIITIS 22 0.0062
391 LEUKOPENIA 311 0.0062
392 BLOOD CREATININE INCREASED 405 0.0062
393 FACE OEDEMA 104 0.0062
394 APNOEA 48 0.0062
395 LYMPHOPENIA 87 0.0061
396 DRUG LEVEL ABOVE THERAPEUTIC 28 0.0061
397 AORTIC VALVE INCOMPETENCE 26 0.0061
398 HYPOMAGNESAEMIA 85 0.0061
399 BLOOD ALKALINE PHOSPHATASE INCREASED 151 0.0061
400 HEPATOTOXICITY 134 0.0060
401 CARDIAC FAILURE ACUTE 40 0.0060
402 HEPATIC ENCEPHALOPATHY 56 0.0060
403 EXPOSURE DURING PREGNANCY 372 0.0060
404 FOETAL EXPOSURE DURING PREGNANCY 486 0.0060
405 GENERALISED OEDEMA 74 0.0060
406 ALTERED STATE OF CONSCIOUSNESS 129 0.0059
407 SEROTONIN SYNDROME 114 0.0059
408 BLOOD LACTATE DEHYDROGENASE INCREASED 94 0.0059
409 BLOOD CALCIUM INCREASED 52 0.0059
410 GAMMA-GLUTAMYLTRANSFERASE INCREASED 131 0.0059
411 HYPERKALAEMIA 207 0.0059
412 CHOLECYSTITIS 70 0.0059
413 VENTRICULAR TACHYCARDIA 97 0.0059
414 ISCHAEMIA 27 0.0059
415 HYPERLIPIDAEMIA 70 0.0059
416 RHABDOMYOLYSIS 244 0.0058
417 BRONCHOPNEUMONIA 20 0.0058
418 ABDOMINAL TENDERNESS 29 0.0058
419 BACTERIAL SEPSIS 19 0.0058
420 C-REACTIVE PROTEIN INCREASED 212 0.0058
421 JAUNDICE 156 0.0058
422 ATRIOVENTRICULAR BLOCK FIRST DEGREE 25 0.0058
423 ATAXIA 68 0.0057
424 MALNUTRITION 64 0.0057
425 DYSPHEMIA 25 0.0057
426 HYDROCEPHALUS 31 0.0057
427 MYOSITIS 51 0.0057
428 WOUND HAEMORRHAGE 21 0.0057
429 HYPERVOLAEMIA 28 0.0057
430 OBSTRUCTIVE AIRWAYS DISORDER 63 0.0057
431 RHINOVIRUS INFECTION 22 0.0056
432 ORGANISING PNEUMONIA 28 0.0056
433 HYPERTRIGLYCERIDAEMIA 33 0.0056
434 SUPRAVENTRICULAR TACHYCARDIA 53 0.0055
435 LACTIC ACIDOSIS 179 0.0055
436 NEURALGIA 134 0.0055
437 DELIRIUM 191 0.0055
438 NASAL POLYPS 27 0.0055
439 UPPER GASTROINTESTINAL HAEMORRHAGE 92 0.0055
440 TRICUSPID VALVE INCOMPETENCE 43 0.0054
441 PULMONARY TOXICITY 38 0.0054
442 PULMONARY HAEMORRHAGE 42 0.0054
443 PLATELET COUNT INCREASED 70 0.0054
444 VENOUS THROMBOSIS 21 0.0053
445 BRONCHIECTASIS 36 0.0053
446 NEUROLEPTIC MALIGNANT SYNDROME 63 0.0053
447 ULCER 84 0.0053
448 LIVE BIRTH 44 0.0053
449 ELECTROLYTE IMBALANCE 61 0.0052
450 MYOCARDITIS 60 0.0052
451 PERICARDIAL EFFUSION 121 0.0052
452 NEUTROPENIA 709 0.0052
453 DRUG LEVEL INCREASED 86 0.0052
454 MATERNAL EXPOSURE DURING PREGNANCY 463 0.0052
455 HEPATIC FAILURE 155 0.0051
456 PYREXIA 1775 0.0051
457 BONE MARROW FAILURE 104 0.0051
458 ECCHYMOSIS 35 0.0051
459 BLOOD ALBUMIN DECREASED 40 0.0050
460 PANCREATITIS ACUTE 113 0.0050
461 TACHYCARDIA 445 0.0050
462 PERIORBITAL OEDEMA 26 0.0050
463 CYTOPENIA 61 0.0050
464 HAEMOPTYSIS 138 0.0049
465 ESCHERICHIA URINARY TRACT INFECTION 21 0.0049
466 LEFT VENTRICULAR DYSFUNCTION 33 0.0049
467 CARDIO-RESPIRATORY ARREST 206 0.0049
468 BRONCHOSPASM 70 0.0049
469 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 20 0.0049
470 TUMOUR LYSIS SYNDROME 43 0.0049
471 PAPILLOEDEMA 22 0.0049
472 BRADYCARDIA 257 0.0048
473 THERAPY NON-RESPONDER 217 0.0048
474 RED CELL DISTRIBUTION WIDTH INCREASED 20 0.0048
475 ABSCESS 76 0.0048
476 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 28 0.0047
477 CONDITION AGGRAVATED 1427 0.0047
478 ENTEROCOLITIS 27 0.0047
479 RENAL FAILURE 621 0.0047
480 CEREBRAL ISCHAEMIA 24 0.0047
481 CIRCULATORY COLLAPSE 79 0.0046
482 CARDIAC MURMUR 40 0.0046
483 APLASTIC ANAEMIA 24 0.0046
484 EOSINOPHIL COUNT INCREASED 38 0.0046
485 PNEUMONITIS 124 0.0045
486 SPUTUM DISCOLOURED 43 0.0045
487 POLYNEUROPATHY 54 0.0045
488 HYPOTENSION 901 0.0045
489 EPSTEIN-BARR VIRUS INFECTION 28 0.0045
490 ASPIRATION 49 0.0045
491 EMPHYSEMA 45 0.0045
492 SUSPECTED OFF LABEL USE 20 0.0044
493 GENERAL PHYSICAL HEALTH DETERIORATION 512 0.0044
494 DEVICE RELATED INFECTION 68 0.0044
495 BLOOD BILIRUBIN INCREASED 119 0.0044
496 ATRIAL FLUTTER 35 0.0044
497 CORONAVIRUS INFECTION 29 0.0044
498 LIVER FUNCTION TEST ABNORMAL 127 0.0044
499 INTESTINAL ISCHAEMIA 24 0.0044
500 RENAL IMPAIRMENT 364 0.0043
501 ARTHRITIS INFECTIVE 20 0.0043
502 FEBRILE NEUTROPENIA 286 0.0043
503 DECUBITUS ULCER 35 0.0043
504 ADRENAL INSUFFICIENCY 52 0.0043
505 HYPOVOLAEMIA 25 0.0043
506 DEPRESSED LEVEL OF CONSCIOUSNESS 169 0.0043
507 UPPER-AIRWAY COUGH SYNDROME 35 0.0042
508 ANGIOEDEMA 187 0.0042
509 HAEMORRHAGE INTRACRANIAL 63 0.0042
510 CYTOMEGALOVIRUS INFECTION 70 0.0042
511 OESOPHAGITIS 46 0.0042
512 LYMPHADENOPATHY 149 0.0042
513 CARDIAC TAMPONADE 20 0.0042
514 IMMUNOSUPPRESSION 37 0.0042
515 ODYNOPHAGIA 25 0.0042
516 GASTROENTERITIS 61 0.0042
517 MYOPATHY 36 0.0042
518 ENDOPHTHALMITIS 25 0.0042
519 PNEUMONIA ASPIRATION 104 0.0042
520 POLYURIA 34 0.0041
521 HYPOTHERMIA 42 0.0041
522 HAEMATURIA 142 0.0041
523 HYPERCHOLESTEROLAEMIA 40 0.0041
524 STILLBIRTH 20 0.0041
525 METABOLIC DISORDER 24 0.0041
526 OFF LABEL USE 3609 0.0041
527 PULMONARY EMBOLISM 391 0.0041
528 WHITE BLOOD CELL COUNT INCREASED 157 0.0041
529 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 42 0.0041
530 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 39 0.0041
531 CACHEXIA 21 0.0041
532 LIPASE INCREASED 31 0.0040
533 HYPERGLYCAEMIA 146 0.0040
534 HYPERAMMONAEMIA 20 0.0040
535 EMBOLISM 33 0.0040
536 OXYGEN SATURATION DECREASED 223 0.0040
537 HYPOCALCAEMIA 75 0.0040
538 LYMPHOCYTE COUNT DECREASED 70 0.0040
539 ANAEMIA 755 0.0040
540 HYPOGAMMAGLOBULINAEMIA 26 0.0040
541 BLOOD TEST ABNORMAL 55 0.0039
542 RENAL CYST 31 0.0039
543 MELAENA 85 0.0039
544 HAEMATOMA 100 0.0039
545 NEPHROPATHY 36 0.0039
546 BLOOD CREATINE PHOSPHOKINASE INCREASED 111 0.0039
547 HERPES SIMPLEX 25 0.0038
548 RASH ERYTHEMATOUS 182 0.0038
549 BODY TEMPERATURE INCREASED 77 0.0038
550 CEREBRAL HAEMORRHAGE 135 0.0038
551 PULMONARY MASS 56 0.0038
552 SKIN LESION 103 0.0038
553 CHRONIC KIDNEY DISEASE 285 0.0037
554 GOUT 67 0.0037
555 ANAL ABSCESS 20 0.0037
556 MITRAL VALVE INCOMPETENCE 42 0.0037
557 FLUID OVERLOAD 54 0.0037
558 HAEMATOCRIT DECREASED 73 0.0037
559 HEMIPARESIS 62 0.0037
560 ACUTE MYOCARDIAL INFARCTION 107 0.0036
561 ACUTE CORONARY SYNDROME 30 0.0036
562 APHTHOUS ULCER 28 0.0036
563 CAESAREAN SECTION 42 0.0036
564 MICTURITION URGENCY 41 0.0036
565 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 186 0.0036
566 PAPULE 25 0.0035
567 ORAL DISORDER 26 0.0035
568 PREMATURE LABOUR 20 0.0035
569 HEPATIC FUNCTION ABNORMAL 131 0.0035
570 HYPOTONIA 35 0.0035
571 TREATMENT FAILURE 290 0.0035
572 NERVOUS SYSTEM DISORDER 109 0.0035
573 PROTEINURIA 66 0.0035
574 HALLUCINATION, VISUAL 73 0.0035
575 SUBARACHNOID HAEMORRHAGE 35 0.0034
576 HYPOGLYCAEMIA 166 0.0034
577 CARDIOMEGALY 42 0.0034
578 COLITIS 129 0.0034
579 FACIAL PARALYSIS 29 0.0034
580 PNEUMONIA 1101 0.0034
581 PRODUCT USE IN UNAPPROVED INDICATION 838 0.0034
582 PLEURISY 20 0.0034
583 NEUTROPENIC SEPSIS 24 0.0034
584 IRON DEFICIENCY ANAEMIA 31 0.0034
585 RECALLED PRODUCT ADMINISTERED 32 0.0034
586 WHEEZING 197 0.0033
587 ECONOMIC PROBLEM 50 0.0033
588 LUNG DISORDER 161 0.0033
589 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 29 0.0033
590 THERAPY PARTIAL RESPONDER 51 0.0033
591 EYE INFLAMMATION 31 0.0032
592 OROPHARYNGEAL DISCOMFORT 29 0.0032
593 BRAIN INJURY 32 0.0032
594 URINARY RETENTION 106 0.0032
595 GLOMERULAR FILTRATION RATE DECREASED 39 0.0032
596 RENAL INJURY 94 0.0032
597 ENTERITIS 20 0.0031
598 COLITIS ISCHAEMIC 21 0.0031
599 DIARRHOEA HAEMORRHAGIC 29 0.0031
600 ABDOMINAL PAIN 719 0.0031
601 COMA 147 0.0031
602 PULMONARY OEDEMA 137 0.0031
603 HEPATIC CIRRHOSIS 57 0.0030
604 AGITATION 222 0.0030
605 AUTOIMMUNE HEPATITIS 21 0.0030
606 REBOUND EFFECT 34 0.0030
607 RESPIRATORY DISORDER 90 0.0030
608 SUBDURAL HAEMATOMA 43 0.0030
609 MOUTH HAEMORRHAGE 22 0.0030
610 HYPERCALCAEMIA 37 0.0030
611 BLOOD POTASSIUM DECREASED 89 0.0030
612 OEDEMA 160 0.0029
613 CHROMATURIA 66 0.0029
614 DYSARTHRIA 110 0.0029
615 CELLULITIS 147 0.0029
616 ABDOMINAL DISTENSION 303 0.0029
617 MYOCARDIAL ISCHAEMIA 33 0.0029
618 RASH GENERALISED 75 0.0029
619 ANHEDONIA 76 0.0029
620 EPILEPSY 87 0.0028
621 PARAESTHESIA ORAL 41 0.0028
622 SALIVARY HYPERSECRETION 28 0.0028
623 NEUTROPHIL COUNT DECREASED 114 0.0028
624 VENTRICULAR EXTRASYSTOLES 29 0.0028
625 GASTRIC ULCER 53 0.0028
626 DERMATITIS ALLERGIC 35 0.0028
627 HYPOKINESIA 40 0.0028
628 CYTOKINE RELEASE SYNDROME 55 0.0027
629 ATRIAL FIBRILLATION 267 0.0027
630 DEEP VEIN THROMBOSIS 178 0.0027
631 RASH PRURITIC 148 0.0027
632 LIVER DISORDER 121 0.0027
633 PARALYSIS 39 0.0027
634 DERMATITIS 57 0.0027
635 PALLOR 74 0.0027
636 NO THERAPEUTIC RESPONSE 33 0.0027
637 FUNGAL INFECTION 90 0.0027
638 PULMONARY HYPERTENSION 55 0.0026
639 TRANSPLANT REJECTION 21 0.0026
640 DIALYSIS 37 0.0026
641 DISEASE PROGRESSION 308 0.0026
642 GRAND MAL CONVULSION 24 0.0026
643 URTICARIA 434 0.0026
644 SKIN INFECTION 29 0.0026
645 MUSCULOSKELETAL CHEST PAIN 40 0.0026
646 INFUSION RELATED REACTION 171 0.0026
647 INTERSTITIAL LUNG DISEASE 124 0.0026
648 HEPATIC ENZYME INCREASED 174 0.0025
649 CONFUSIONAL STATE 411 0.0025
650 NEUTROPHIL COUNT INCREASED 26 0.0025
651 HEPATIC STEATOSIS 47 0.0025
652 PANCREATITIS 133 0.0025
653 DRUG INEFFECTIVE 3316 0.0025
654 URINARY TRACT INFECTION 429 0.0025
655 CHILLS 294 0.0025
656 RESPIRATORY ARREST 69 0.0025
657 SKIN PLAQUE 21 0.0025
658 HAEMATEMESIS 63 0.0025
659 RHINITIS 20 0.0025
660 SKIN ULCER 64 0.0025
661 UPPER RESPIRATORY TRACT INFECTION 114 0.0025
662 BLOOD CHOLESTEROL INCREASED 115 0.0025
663 CARDIAC FAILURE 197 0.0025
664 EJECTION FRACTION DECREASED 38 0.0024
665 ARTERIOSCLEROSIS 23 0.0024
666 RIB FRACTURE 50 0.0024
667 OEDEMA PERIPHERAL 296 0.0024
668 HAEMOGLOBIN DECREASED 249 0.0024
669 APHASIA 73 0.0024
670 SOPOR 32 0.0024
671 CEREBRAL INFARCTION 59 0.0024
672 SEIZURE 278 0.0024
673 HEMIPLEGIA 20 0.0024
674 CENTRAL NERVOUS SYSTEM LESION 33 0.0024
675 BLOOD CALCIUM DECREASED 27 0.0024
676 PULMONARY FIBROSIS 46 0.0024
677 THROMBOSIS 192 0.0024
678 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 69 0.0024
679 ISCHAEMIC STROKE 42 0.0024
680 DISORIENTATION 92 0.0023
681 GASTRITIS 61 0.0023
682 BLOOD MAGNESIUM DECREASED 20 0.0023
683 SECRETION DISCHARGE 29 0.0023
684 DIPLOPIA 60 0.0023
685 MYELOSUPPRESSION 83 0.0023
686 PRODUCTIVE COUGH 110 0.0023
687 INTENTIONAL PRODUCT USE ISSUE 201 0.0023
688 RESPIRATORY DEPRESSION 28 0.0023
689 SPINAL OSTEOARTHRITIS 20 0.0023
690 JOINT DISLOCATION 24 0.0023
691 PLATELET COUNT DECREASED 241 0.0023
692 VITAMIN D DEFICIENCY 22 0.0023
693 CORONARY ARTERY DISEASE 68 0.0022
694 CARDIOTOXICITY 20 0.0022
695 PHOTOSENSITIVITY REACTION 37 0.0022
696 PHOTOPHOBIA 42 0.0022
697 CARDIOMYOPATHY 33 0.0022
698 INTESTINAL PERFORATION 25 0.0022
699 VOMITING 1039 0.0022
700 DISEASE RECURRENCE 105 0.0022
701 PULMONARY CONGESTION 29 0.0022
702 TENDON RUPTURE 27 0.0022
703 ACUTE MYELOID LEUKAEMIA 34 0.0022
704 PERITONITIS 45 0.0022
705 ILEUS 27 0.0022
706 GASTROINTESTINAL HAEMORRHAGE 180 0.0022
707 RASH MACULAR 75 0.0021
708 SNEEZING 48 0.0021
709 MUCOSAL INFLAMMATION 56 0.0021
710 LOWER RESPIRATORY TRACT INFECTION 97 0.0021
711 DRUG INTOLERANCE 206 0.0021
712 COVID-19 370 0.0021
713 PHARYNGITIS 26 0.0021
714 NEPHROLITHIASIS 96 0.0021
715 DIABETES MELLITUS 159 0.0021
716 PRODUCT PRESCRIBING ISSUE 45 0.0021
717 EYELID OEDEMA 24 0.0021
718 DRUG LEVEL DECREASED 21 0.0021
719 TOXICITY TO VARIOUS AGENTS 347 0.0021
720 RASH PAPULAR 46 0.0021
721 BLISTER 115 0.0020
722 DRY MOUTH 166 0.0020
723 DYSPHAGIA 193 0.0020
724 INFECTION 293 0.0020
725 DYSPNOEA 1143 0.0020
726 PRESYNCOPE 49 0.0020
727 DYSURIA 74 0.0020
728 RASH 876 0.0020
729 OBESITY 32 0.0020
730 MYELODYSPLASTIC SYNDROME 29 0.0020
731 EXPIRED PRODUCT ADMINISTERED 65 0.0020
732 SMALL INTESTINAL OBSTRUCTION 24 0.0019
733 COLD SWEAT 34 0.0019
734 SWELLING 180 0.0019
735 TENDERNESS 20 0.0019
736 CYSTITIS 61 0.0019
737 LETHARGY 110 0.0019
738 ARRHYTHMIA 90 0.0019
739 RED BLOOD CELL SEDIMENTATION RATE INCREASED 21 0.0019
740 SARS-COV-2 TEST POSITIVE 25 0.0019
741 SUDDEN DEATH 20 0.0019
742 SLEEP DISORDER 133 0.0019
743 DERMATITIS CONTACT 21 0.0018
744 SKIN LACERATION 20 0.0018
745 ERYTHEMA 375 0.0018
746 INTENTIONAL PRODUCT MISUSE 159 0.0018
747 PRURITUS GENERALISED 39 0.0018
748 LUNG INFECTION 28 0.0018
749 CONSTIPATION 392 0.0018
750 HYPERSENSITIVITY 331 0.0018
751 SOMNOLENCE 357 0.0018
752 LIP SWELLING 59 0.0018
753 RESPIRATORY TRACT INFECTION 46 0.0018
754 COUGH 495 0.0018
755 ASTHMA 199 0.0018
756 MOUTH ULCERATION 37 0.0018
757 PERIPHERAL COLDNESS 24 0.0017
758 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 124 0.0017
759 PLASMA CELL MYELOMA 68 0.0017
760 DYSKINESIA 70 0.0017
761 COGNITIVE DISORDER 79 0.0017
762 JOINT INJURY 36 0.0017
763 HYPOPHAGIA 43 0.0017
764 MUSCLE RIGIDITY 20 0.0017
765 CHEST DISCOMFORT 171 0.0017
766 RESTLESSNESS 61 0.0017
767 INFLAMMATION 86 0.0017
768 BLOOD POTASSIUM INCREASED 27 0.0017
769 METASTASES TO LIVER 29 0.0016
770 DYSPNOEA EXERTIONAL 62 0.0016
771 BLOOD SODIUM DECREASED 31 0.0016
772 SWELLING FACE 106 0.0016
773 BLOOD PRESSURE DECREASED 108 0.0016
774 CONJUNCTIVITIS 30 0.0016
775 EAR INFECTION 43 0.0016
776 CARDIOVASCULAR DISORDER 41 0.0016
777 DEAFNESS 42 0.0016
778 SPEECH DISORDER 83 0.0016
779 EPISTAXIS 117 0.0016
780 DEHYDRATION 208 0.0016
781 HIATUS HERNIA 20 0.0015
782 HAEMATOCHEZIA 85 0.0015
783 BLOOD COUNT ABNORMAL 23 0.0015
784 OSTEOPENIA 23 0.0015
785 OSTEOPOROSIS 62 0.0015
786 CONVULSION 86 0.0015
787 VIRAL INFECTION 50 0.0015
788 MEDICATION ERROR 83 0.0015
789 BLOOD PRESSURE SYSTOLIC INCREASED 29 0.0015
790 CHEST PAIN 274 0.0015
791 IMMUNODEFICIENCY 22 0.0015
792 BLOOD TRIGLYCERIDES INCREASED 26 0.0015
793 PRURITUS 565 0.0015
794 CRYING 53 0.0015
795 LABORATORY TEST ABNORMAL 43 0.0015
796 URINARY INCONTINENCE 43 0.0014
797 HYPERTENSION 304 0.0014
798 ORAL HERPES 28 0.0014
799 RED BLOOD CELL COUNT DECREASED 41 0.0014
800 DIARRHOEA 921 0.0014
801 DELUSION 22 0.0014
802 EXTRAPYRAMIDAL DISORDER 35 0.0014
803 THROAT TIGHTNESS 38 0.0014
804 SYNCOPE 140 0.0014
805 RECTAL HAEMORRHAGE 60 0.0014
806 HALLUCINATION, AUDITORY 22 0.0014
807 BRONCHITIS 102 0.0014
808 PERICARDITIS 23 0.0014
809 NEUROPATHY PERIPHERAL 130 0.0014
810 MUSCLE TIGHTNESS 22 0.0014
811 DIABETES MELLITUS INADEQUATE CONTROL 24 0.0014
812 SWOLLEN TONGUE 42 0.0013
813 HYPERHIDROSIS 173 0.0013
814 WHITE BLOOD CELL COUNT DECREASED 145 0.0013
815 SINUSITIS 137 0.0013
816 MUSCULOSKELETAL STIFFNESS 117 0.0013
817 PSYCHOMOTOR HYPERACTIVITY 22 0.0013
818 LACRIMATION INCREASED 40 0.0013
819 ASTHENIA 497 0.0013
820 HEART RATE DECREASED 46 0.0013
821 POST PROCEDURAL COMPLICATION 25 0.0013
822 RHINORRHOEA 84 0.0013
823 OSTEONECROSIS OF JAW 32 0.0013
824 LIMB DISCOMFORT 40 0.0013
825 GASTROOESOPHAGEAL REFLUX DISEASE 104 0.0013
826 ABDOMINAL PAIN LOWER 32 0.0013
827 LOSS OF CONSCIOUSNESS 162 0.0013
828 TREMOR 209 0.0013
829 NAUSEA 996 0.0013
830 MUSCULAR WEAKNESS 143 0.0013
831 IMPAIRED HEALING 41 0.0012
832 DYSTONIA 24 0.0012
833 DECREASED APPETITE 285 0.0012
834 TREATMENT NONCOMPLIANCE 67 0.0012
835 MANIA 20 0.0012
836 POOR QUALITY SLEEP 26 0.0012
837 HEART RATE INCREASED 119 0.0012
838 ABORTION SPONTANEOUS 48 0.0012
839 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 57 0.0012
840 TRANSIENT ISCHAEMIC ATTACK 40 0.0012
841 DYSPHONIA 69 0.0012
842 NIGHT SWEATS 38 0.0012
843 MYALGIA 200 0.0012
844 PRODUCT PRESCRIBING ERROR 28 0.0012
845 KIDNEY INFECTION 23 0.0012
846 DIABETIC KETOACIDOSIS 28 0.0012
847 TOOTH LOSS 24 0.0012
848 DIVERTICULITIS 32 0.0012
849 UPPER LIMB FRACTURE 23 0.0012
850 ABNORMAL BEHAVIOUR 45 0.0011
851 OSTEOARTHRITIS 48 0.0011
852 GASTROINTESTINAL DISORDER 101 0.0011
853 HYPOTHYROIDISM 36 0.0011
854 NASAL CONGESTION 66 0.0011
855 HAEMORRHAGE 117 0.0011
856 ORAL PAIN 25 0.0011
857 SEDATION 29 0.0011
858 SKIN EXFOLIATION 91 0.0011
859 STOMATITIS 65 0.0011
860 INJURY 75 0.0011
861 MOVEMENT DISORDER 34 0.0011
862 NO ADVERSE EVENT 190 0.0010
863 MALIGNANT NEOPLASM PROGRESSION 107 0.0010
864 TINNITUS 48 0.0010
865 PRODUCT USE ISSUE 195 0.0010
866 FEEDING DISORDER 21 0.0010
867 BLINDNESS 42 0.0010
868 BLOOD PRESSURE ABNORMAL 20 0.0010
869 THERAPY CESSATION 51 0.0010
870 CONTRAINDICATED PRODUCT ADMINISTERED 30 0.0010
871 PAIN IN JAW 28 0.0010
872 CARDIAC FAILURE CONGESTIVE 79 0.0010
873 EYE PRURITUS 33 0.0010
874 OSTEONECROSIS 32 0.0010
875 VERTIGO 59 0.0010
876 FLUSHING 98 0.0010
877 HALLUCINATION 72 0.0010
878 PSYCHOTIC DISORDER 28 0.0009
879 RENAL DISORDER 44 0.0009
880 RETCHING 20 0.0009
881 INTESTINAL OBSTRUCTION 35 0.0009
882 PARAESTHESIA 146 0.0009
883 AGGRESSION 46 0.0009
884 WEIGHT DECREASED 255 0.0009
885 OROPHARYNGEAL PAIN 84 0.0009
886 BLOOD PRESSURE INCREASED 138 0.0009
887 SKIN DISORDER 30 0.0009
888 BACK PAIN 208 0.0009
889 FEAR 24 0.0009
890 EMOTIONAL DISTRESS 106 0.0009
891 ANXIETY 249 0.0009
892 HERPES ZOSTER 50 0.0009
893 LOCALISED INFECTION 21 0.0009
894 BONE DENSITY DECREASED 27 0.0009
895 COLITIS ULCERATIVE 38 0.0008
896 ANGINA PECTORIS 24 0.0008
897 MENTAL IMPAIRMENT 20 0.0008
898 OVERDOSE 173 0.0008
899 ARTHRITIS 62 0.0008
900 WOUND 22 0.0008
901 INFLUENZA 87 0.0008
902 THERAPEUTIC RESPONSE DECREASED 47 0.0008
903 MOBILITY DECREASED 55 0.0008
904 MALAISE 335 0.0008
905 DISTURBANCE IN ATTENTION 41 0.0008
906 CEREBROVASCULAR ACCIDENT 126 0.0007
907 BURNING SENSATION 52 0.0007
908 ABDOMINAL PAIN UPPER 152 0.0007
909 BONE PAIN 43 0.0007
910 PAIN 446 0.0007
911 FEELING HOT 44 0.0007
912 FALL 238 0.0007
913 THROAT IRRITATION 32 0.0007
914 ADVERSE DRUG REACTION 63 0.0007
915 NECK PAIN 39 0.0007
916 HEADACHE 432 0.0007
917 MUSCULOSKELETAL PAIN 36 0.0007
918 FATIGUE 527 0.0007
919 EYE SWELLING 25 0.0007
920 ECZEMA 35 0.0007
921 UNEVALUABLE EVENT 50 0.0007
922 PERIPHERAL SWELLING 101 0.0007
923 SKIN DISCOLOURATION 30 0.0007
924 ARTHRALGIA 266 0.0006
925 VISUAL ACUITY REDUCED 21 0.0006
926 HEAD INJURY 20 0.0006
927 FLUID RETENTION 32 0.0006
928 THERAPEUTIC RESPONSE UNEXPECTED 28 0.0006
929 PAIN IN EXTREMITY 183 0.0006
930 DIZZINESS 309 0.0006
931 INCORRECT ROUTE OF DRUG ADMINISTRATION 22 0.0006
932 HYPOAESTHESIA 92 0.0006
933 MYOCARDIAL INFARCTION 107 0.0006
934 GAIT DISTURBANCE 117 0.0006
935 OCULAR HYPERAEMIA 29 0.0006
936 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 109 0.0006
937 HYPOACUSIS 26 0.0006
938 ILLNESS 62 0.0006
939 DEATH 517 0.0006
940 MENTAL DISORDER 26 0.0006
941 PALPITATIONS 69 0.0006
942 AMNESIA 38 0.0006
943 IRRITABILITY 35 0.0006
944 DRY EYE 29 0.0006
945 DRUG EFFECT INCOMPLETE 21 0.0006
946 ACCIDENTAL OVERDOSE 21 0.0006
947 DISCOMFORT 35 0.0006
948 WITHDRAWAL SYNDROME 24 0.0006
949 SYSTEMIC LUPUS ERYTHEMATOSUS 20 0.0006
950 VISION BLURRED 75 0.0005
951 CARDIAC DISORDER 50 0.0005
952 SUICIDE ATTEMPT 31 0.0005
953 DRUG WITHDRAWAL SYNDROME 44 0.0005
954 ABDOMINAL DISCOMFORT 84 0.0005
955 HOT FLUSH 37 0.0005
956 NASOPHARYNGITIS 90 0.0005
957 POLLAKIURIA 20 0.0005
958 FLATULENCE 27 0.0005
959 DEPRESSED MOOD 25 0.0005
960 VISUAL IMPAIRMENT 58 0.0005
961 DYSPEPSIA 46 0.0005
962 INTENTIONAL OVERDOSE 29 0.0005
963 EYE PAIN 25 0.0004
964 BALANCE DISORDER 38 0.0004
965 INSOMNIA 114 0.0004
966 PRODUCT DOSE OMISSION ISSUE 125 0.0004
967 MUSCLE SPASMS 78 0.0004
968 DEPRESSION 92 0.0004
969 BREAST CANCER 37 0.0004
970 ARTHROPATHY 22 0.0004
971 WEIGHT INCREASED 84 0.0004
972 INFLUENZA LIKE ILLNESS 30 0.0004
973 MEMORY IMPAIRMENT 50 0.0004
974 DRUG ABUSE 30 0.0004
975 MIGRAINE 34 0.0004
976 BLOOD GLUCOSE INCREASED 67 0.0004
977 CATARACT 21 0.0004
978 PRODUCT SUBSTITUTION ISSUE 20 0.0003
979 CONTUSION 31 0.0003
980 ADVERSE EVENT 29 0.0003
981 FEELING ABNORMAL 75 0.0003
982 HOSPITALISATION 48 0.0003
983 INCORRECT DOSE ADMINISTERED 71 0.0003
984 DYSGEUSIA 23 0.0003
985 THERAPY INTERRUPTED 22 0.0003
986 UNDERDOSE 22 0.0003
987 JOINT SWELLING 33 0.0003
988 SUICIDAL IDEATION 23 0.0003
989 PSORIASIS 31 0.0002
990 PRODUCT QUALITY ISSUE 30 0.0002
991 ALOPECIA 42 0.0002
992 DRY SKIN 24 0.0002
993 INJECTION SITE PAIN 45 0.0001
994 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 28 0.0001